Skip to main content
  • How to Use
    • For Personal Use
    • For Health Professionals
    • For Schools
    • For Businesses
    • Variant Info
    • Expiration Extension
    • Insurance
    • Web App
    • Press Releases
    • Documentos en Español
  • FAQ
  • Where to Buy
Skip to main content
  • How to Use
    • For Personal Use
    • For Health Professionals
    • For Schools
    • For Businesses
    • Variant Info
    • Expiration Extension
    • Insurance
    • Web App
    • Press Releases
    • Documentos en Español
  • FAQ
  • Where to Buy

How to Use

InteliSwab® COVID-19 Rapid Test Training Video & Instructions

Select video version:

  • Video Transcript (English)
  • Instructions for Use HTML (English)
  • Instructions for Use PDF (English)

Other InteliSwab® COVID-19 Rapid Test Resources

  • Healthcare Provider IFU
  • Healthcare Provider Fact Sheet
  • Package Label
  • Letter of Authorization

InteliSwab® COVID-19 Rapid Test Pro Training Video & Instructions

Healthcare Provider IFU (Pro)

Other InteliSwab® COVID-19 Rapid Test Pro Resources

  • Kit Control IFU (English)
  • Patient Fact Sheet
  • Healthcare Provider Fact Sheet (Pro)
  • Quick Reference Guide
  • Visual Reference Panel IFU
  • Letter of Authorization

Documentos en Español

InteliSwab® COVID-19 Rapid Test Rx Documents

  • Home
  • How to Use
  • Personal Use
  • Health Professionals
  • Frequently Asked Questions
  • Where to Buy
  • Privacy Policy
  • Update Policy
  • Quality Policy
  • Usage Terms
  • Supplier Transparency
  • CA Declaration of Compliance
  • Product Terms & Conditions

This product has not been FDA cleared or approved; but has been authorized by FDA under an EUA. The emergency use of this product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. This product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb- 3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

© 2025 OraSure Technologies, Inc. All Rights Reserved.